225 related articles for article (PubMed ID: 15975637)
1. Serious workings of the funny current.
DiFrancesco D
Prog Biophys Mol Biol; 2006; 90(1-3):13-25. PubMed ID: 15975637
[TBL] [Abstract][Full Text] [Related]
2. The role of the funny current in pacemaker activity.
DiFrancesco D
Circ Res; 2010 Feb; 106(3):434-46. PubMed ID: 20167941
[TBL] [Abstract][Full Text] [Related]
3. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.
DiFrancesco D
Pharmacol Res; 2006 May; 53(5):399-406. PubMed ID: 16638640
[TBL] [Abstract][Full Text] [Related]
4. Pacemaker channels.
Baruscotti M; Difrancesco D
Ann N Y Acad Sci; 2004 May; 1015():111-21. PubMed ID: 15201153
[TBL] [Abstract][Full Text] [Related]
5. Physiology and pharmacology of the cardiac pacemaker ("funny") current.
Baruscotti M; Bucchi A; Difrancesco D
Pharmacol Ther; 2005 Jul; 107(1):59-79. PubMed ID: 15963351
[TBL] [Abstract][Full Text] [Related]
6. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
DiFrancesco D
Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
[TBL] [Abstract][Full Text] [Related]
7. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
[TBL] [Abstract][Full Text] [Related]
8. Heart rate reduction via selective 'funny' channel blockers.
Bucchi A; Barbuti A; Baruscotti M; DiFrancesco D
Curr Opin Pharmacol; 2007 Apr; 7(2):208-13. PubMed ID: 17267284
[TBL] [Abstract][Full Text] [Related]
9. Control of cardiac rate by "funny" channels in health and disease.
Barbuti A; DiFrancesco D
Ann N Y Acad Sci; 2008 Mar; 1123():213-23. PubMed ID: 18375593
[TBL] [Abstract][Full Text] [Related]
10. The funny current: cellular basis for the control of heart rate.
DiFrancesco D; Borer JS
Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing.
Kashiwakura Y; Cho HC; Barth AS; Azene E; Marbán E
Circulation; 2006 Oct; 114(16):1682-6. PubMed ID: 17030681
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibition of cardiac hyperpolarization-activated cyclic nucleotide-gated pacemaker channels by clonidine.
Knaus A; Zong X; Beetz N; Jahns R; Lohse MJ; Biel M; Hein L
Circulation; 2007 Feb; 115(7):872-80. PubMed ID: 17261653
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
14. Molecular regulation and pharmacology of pacemaker channels.
Bois P; Guinamard R; Chemaly AE; Faivre JF; Bescond J
Curr Pharm Des; 2007; 13(23):2338-49. PubMed ID: 17692005
[TBL] [Abstract][Full Text] [Related]
15. Hyperpolarization-activated cyclic nucleotide-gated channel gene: the most possible therapeutic applications in the field of cardiac biological pacemakers.
Zhou YF; Yang XJ; Li HX
Med Hypotheses; 2007; 69(3):541-4. PubMed ID: 17367954
[TBL] [Abstract][Full Text] [Related]
16. Pacemaking by HCN channels requires interaction with phosphoinositides.
Zolles G; Klöcker N; Wenzel D; Weisser-Thomas J; Fleischmann BK; Roeper J; Fakler B
Neuron; 2006 Dec; 52(6):1027-36. PubMed ID: 17178405
[TBL] [Abstract][Full Text] [Related]
17. Drug insight: If inhibitors as specific heart-rate-reducing agents.
Borer JS
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):103-9. PubMed ID: 16265314
[TBL] [Abstract][Full Text] [Related]
18. Hyperpolarization-activated cyclic nucleotide-gated channels and T-type calcium channels confer automaticity of embryonic stem cell-derived cardiomyocytes.
Yanagi K; Takano M; Narazaki G; Uosaki H; Hoshino T; Ishii T; Misaki T; Yamashita JK
Stem Cells; 2007 Nov; 25(11):2712-9. PubMed ID: 17656646
[TBL] [Abstract][Full Text] [Related]
19. Hyperpolarization-activated cation channels: from genes to function.
Biel M; Wahl-Schott C; Michalakis S; Zong X
Physiol Rev; 2009 Jul; 89(3):847-85. PubMed ID: 19584315
[TBL] [Abstract][Full Text] [Related]
20. I(f) inhibition in cardiovascular diseases.
Thollon C; Vilaine JP
Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
